Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines.
Bermudez
L E
LE
Kuzell Institute for Arthritis and Infectious Diseases, Pacific Presbyterian Medical Center, San Francisco, CA.
Young
L S
LS
D000818:Animals; D001685:Biological Factors / Q000276:immunology / Q000494:pharmacology*; D002478:Cells, Cultured; D016207:Cytokines; D006801:Humans; D007376:Interleukin-2 / Q000276:immunology / Q000494:pharmacology; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology* / Q000382:microbiology; D051379:Mice; D015269:Mycobacterium avium Complex / Q000254:growth & development / Q000276:immunology*; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000494:pharmacology
D001685:Biological Factors; D016207:Cytokines; D007376:Interleukin-2; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha